MISSISSAUGA, ON, June 5, 2014 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:
DND) ("Cipher" or "the Company") today announced that Norm Evans, Chief
Financial Officer, is presenting at the 2014 Bloom Burton & Co.
Healthcare Investor Conference, which is being held at the Toronto
Board of Trade. Mr. Evans will provide a corporate update on Wednesday,
June 18, 2014 at 10:00 AM ET followed by a Q&A session.
To learn more about the 2014 Bloom Burton & Co. Healthcare Investor
Conference please visit their website http://bit.ly/cipherbloomburton
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: DND) is a growing specialty pharmaceutical
company with three commercial products and a fourth in development. Our
product candidates are typically improved formulations of successful,
currently marketed drugs. We in-license a product, manage the required
clinical development and regulatory approval process, and either
out-license it to a marketing partner, or, in Canada, we may market the
product ourselves. Our core capabilities are in clinical and regulatory
affairs, product licensing, supply chain management, and marketing and
sales. Since the Company was founded in 2000, we have achieved final
regulatory approval in the U.S. and Canada for all three of our
original products and completed six marketing partnerships, generating
growing licensing revenue.
SOURCE: Cipher Pharmaceuticals Inc.
For further information:
For more information, please contact:
(416) 815-0700 ext 278
(416) 815-0080 fax
Chief Financial Officer
(905) 602-5840 ext 323
(905) 602-0628 fax